Close

HBV

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

The large envelope protein exists in two topological conformations, one which is termed 'external' or Le-HBsAg and the other 'internal' or Li-HBsAg. In its external conformation the protein attaches the virus to cell receptors and thereby initiating infection. This interaction determines the species specificity and liver tropism. This attachment induces virion internalization predominantly through caveolin-mediated endocytosis. The large envelope protein also assumes fusion between virion membrane and endosomal membrane (Probable). In its internal conformation the protein plays a role in virion morphogenesis and mediates the contact with the nucleocapsid like a matrix protein.

Associated Disease
  • Cirrhosis;
  • hepatocellular carcinoma (HCC);
  • liver cancer
  • Hepatoblastoma
  • CAR Vector Products

  • TCR Vector Products

  • AbTCR Vector Products

  • TCR Cell Products

  • CAR Viral Particles

  • TCR Viral Particles

  • TriCAR Vector Products

  • TCR-Like CAR

Loading...
  • Target Species:
  • Antibody Clone:
  • Antibody Host:
  • Receptor Construction:
  • Vector Type:
  • Targeting Cell Type:
CAT Product Name Target Species Antibody Clone Antibody Host Receptor Construction Vector Type Targeting Cell Type CAR Vector Type Inquiry & Datasheet
CAR-T-1-M319-2 Anti-HBV S protein scFv h(CD28) CART, pCDCAR1 Human S 26 Mouse scFv-CD28 Lentiviral T cell   Add to Cart   Datasheet
CAR-T-1-M319-G Anti-HBV S protein scFv h(FcεRIγ) CART, pCDCAR1 Human S 26 Mouse scFv-FcεRIγ Lentiviral T cell   Add to Cart   Datasheet
CAR-T-1-M319-Z Anti-HBV S protein scFv h(CD3ζ) CART, pCDCAR1 Human S 26 Mouse scFv-CD3ζ Lentiviral T cell   Add to Cart   Datasheet
CAR-T-2-M319-2G Anti-HBV S protein scFv h(CD28-FcεRIγ) CART, pCDCAR1 Human S 26 Mouse scFv-CD28-FcεRIγ Lentiviral T cell   Add to Cart   Datasheet
CAR-T-2-M319-2Z Anti-HBV S protein scFv h(CD28-CD3ζ) CART, pCDCAR1 Human S 26 Mouse scFv-CD28-CD3ζ Lentiviral T cell   Add to Cart   Datasheet
CAR-T-2-M319-4G Anti-HBV S protein scFv h(CD4-FcεRIγ) CART, pCDCAR1 Human S 26 Mouse scFv-CD4-FcεRIγ Lentiviral T cell   Add to Cart   Datasheet
CAR-T-2-M319-4Z Anti-HBV S protein scFv h(CD4-CD3ζ) CART, pCDCAR1 Human S 26 Mouse scFv-CD4-CD3ζ Lentiviral T cell   Add to Cart   Datasheet
CAR-T-2-M319-8Z Anti-HBV S protein scFv h(CD8-CD3ζ) CART, pCDCAR1 Human S 26 Mouse scFv-CD8-CD3ζ Lentiviral T cell   Add to Cart   Datasheet
CAR-T-2-M319-BZ Anti-HBV S protein scFv h(41BB-CD3ζ) CART, pCDCAR1 Human S 26 Mouse scFv-41BB-CD3ζ Lentiviral T cell   Add to Cart   Datasheet
CAR-T-2-M319-CZ Anti-HBV S protein scFv h(b2c-CD3ζ) CART, pCDCAR1 Human S 26 Mouse scFv-b2c-CD3ζ Lentiviral T cell   Add to Cart   Datasheet
CAR-T-3-M319-2BZ Anti-HBV S protein scFv h(CD28-41BB-CD3ζ) CART, pCDCAR1 Human S 26 Mouse scFv-CD28-41BB-CD3ζ Lentiviral T cell   Add to Cart   Datasheet
CAR-T-3-M319-2XZ Anti-HBV S protein scFv h(CD28-OX40-CD3ζ) CART, pCDCAR1 Human S 26 Mouse scFv-CD28-OX40-CD3ζ Lentiviral T cell   Add to Cart   Datasheet
Unable to find the desired product? Explore the Filter Options at the top of the list.
Key Updates
Newsletter NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
NOVEL SOLUTION NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
NEW TECHNOLOGY NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.